Several studies have shown that cardiac hypertrophy is induced by the activation of multiple signaling pathways, and the mitogen-activated protein kinase (MAPK) signaling pathway is believed to play an essential pathogenetic role [3, 4]. Here, WNK2 is linked to cardiac hypertrophy.